OncoSec Medical Inc. Receives VBHRC Funding To Study Novel Gene Therapy Approach In Melanoma

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical Inc. (OTCQB:ONCS), a company developing DNA-based intratumoral cancer immunotherapies, along with researchers at Old Dominion University (ODU) and Eastern Virginia Medical School (EVMS), has received a $585,000 grant from the Virginia Biosciences Health Research Corporation (VBHRC) to study a novel gene therapy approach for the treatment of malignant melanoma.

Help employers find you! Check out all the jobs and post your resume.